CURE.DE vs. G2X.DE
CURE.DE (VanEck Genomics and Healthcare Innovators UCITS ETF A) and G2X.DE (VanEck Gold Miners UCITS ETF) are both exchange-traded funds - CURE.DE is a Health & Biotech Equities fund tracking the MVIS Global Future Healthcare ESG, while G2X.DE is a Precious Metals fund tracking the NYSE Arca Gold Miners. Both are passively managed. Over the past 3 years, CURE.DE returned -2.48%/yr vs 37.60%/yr for G2X.DE. At a 0.17 correlation, their price movements are largely independent. CURE.DE charges 0.35%/yr vs 0.53%/yr for G2X.DE.
Performance
CURE.DE vs. G2X.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE.DE achieves a -5.10% return, which is significantly lower than G2X.DE's -1.03% return.
CURE.DE
- 1D
- 4.01%
- 1M
- 6.73%
- YTD
- -5.10%
- 6M
- -8.62%
- 1Y
- 6.04%
- 3Y*
- -2.48%
- 5Y*
- —
- 10Y*
- —
G2X.DE
- 1D
- 1.09%
- 1M
- -5.12%
- YTD
- -1.03%
- 6M
- 7.25%
- 1Y
- 61.18%
- 3Y*
- 37.60%
- 5Y*
- 20.05%
- 10Y*
- 13.83%
CURE.DE vs. G2X.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
CURE.DE VanEck Genomics and Healthcare Innovators UCITS ETF A | -5.10% | 5.09% | 0.30% | -6.42% | -4.35% |
G2X.DE VanEck Gold Miners UCITS ETF | -1.03% | 131.13% | 17.55% | 5.59% | 12.70% |
Correlation
The correlation between CURE.DE and G2X.DE is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Sep 8, 2022 | 0.17 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE.DE vs. G2X.DE — Risk / Return Rank
CURE.DE
G2X.DE
CURE.DE vs. G2X.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) and VanEck Gold Miners UCITS ETF (G2X.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CURE.DE | G2X.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.14 | ||
| Sortino ratioReturn per unit of downside risk | -1.34 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.25 | -0.18 |
| Calmar ratioReturn relative to maximum drawdown | 0.30 | 2.18 | -1.87 |
| Martin ratioReturn relative to average drawdown | 0.68 | 5.49 | -4.81 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CURE.DE | G2X.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.29 | 1.42 | -1.14 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.60 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.43 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.14 | 0.44 | -0.58 |
Drawdowns
CURE.DE vs. G2X.DE - Drawdown Comparison
The maximum CURE.DE drawdown since its inception was -34.80%, smaller than the maximum G2X.DE drawdown of -46.04%. Use the drawdown chart below to compare losses from any high point for CURE.DE and G2X.DE.
Loading charts...
Drawdown Indicators
| CURE.DE | G2X.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -34.80% | -46.04% | +11.24% |
Max Drawdown (1Y)Largest decline over 1 year | -19.07% | -27.90% | +8.83% |
Max Drawdown (3Y)Largest decline over 3 years | -29.32% | -27.90% | -1.42% |
Max Drawdown (5Y)Largest decline over 5 years | — | -38.55% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -46.04% | — |
Current DrawdownCurrent decline from peak | -15.66% | -23.34% | +7.68% |
Average DrawdownAverage peak-to-trough decline | -15.12% | -19.92% | +4.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.53% | 11.09% | -2.56% |
Volatility
CURE.DE vs. G2X.DE - Volatility Comparison
The current volatility for VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) is 5.73%, while VanEck Gold Miners UCITS ETF (G2X.DE) has a volatility of 13.57%. This indicates that CURE.DE experiences smaller price fluctuations and is considered to be less risky than G2X.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE.DE | G2X.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.73% | 13.57% | -7.84% |
Volatility (6M)Calculated over the trailing 6-month period | 15.20% | 34.36% | -19.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.97% | 42.64% | -22.67% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.74% | 33.16% | -12.42% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.74% | 32.33% | -11.59% |
CURE.DE vs. G2X.DE - Expense Ratio Comparison
CURE.DE has a 0.35% expense ratio, which is lower than G2X.DE's 0.53% expense ratio.
Dividends
CURE.DE vs. G2X.DE - Dividend Comparison
Neither CURE.DE nor G2X.DE has paid dividends to shareholders.
Frequently Asked Questions
CURE.DE and G2X.DE have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, CURE.DE is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
CURE.DE is cheaper with a 0.35% expense ratio, compared with 0.53% for G2X.DE.
CURE.DE is categorized as Health & Biotech Equities, while G2X.DE is Precious Metals. CURE.DE tracks MVIS Global Future Healthcare ESG, while G2X.DE tracks NYSE Arca Gold Miners. Their fees differ too: 0.35% for CURE.DE and 0.53% for G2X.DE.
Find the right allocation for CURE.DE and G2X.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer